Your browser doesn't support javascript.
loading
Real-world clinical outcomes of sofosbuvir and velpatasvir treatment in HCV genotype 1- and 2-infected patients with decompensated cirrhosis: A nationwide multicenter study by the Japanese Red Cross Liver Study Group.
Tada, Toshifumi; Kurosaki, Masayuki; Nakamura, Shinichiro; Hasebe, Chitomi; Kojima, Yuji; Furuta, Koichiro; Kobashi, Haruhiko; Kimura, Hiroyuki; Ogawa, Chikara; Yagisawa, Hitoshi; Uchida, Yasushi; Joko, Kouji; Akahane, Takehiro; Arai, Hirotaka; Marusawa, Hiroyuki; Narita, Ryoichi; Ide, Yasushi; Sato, Takashi; Kusakabe, Atsunori; Tsuji, Keiji; Mori, Nami; Kondo, Masahiko; Mitsuda, Akeri; Izumi, Namiki.
Afiliação
  • Tada T; Department of Internal medicine, Japanese Red Cross Himeji Hospital, Hyogo, Japan.
  • Kurosaki M; Department of Gastroenterology and Hepatology, Japanese Red Cross Musashino Hospital, Tokyo, Japan.
  • Nakamura S; Department of Internal medicine, Japanese Red Cross Himeji Hospital, Hyogo, Japan.
  • Hasebe C; Department of Gastroenterology, Japanese Red Cross Asahikawa Hospital, Hokkaido, Japan.
  • Kojima Y; Department of Hepatology, Japanese Red Cross Ise Hospital, Ise, Mie, Japan.
  • Furuta K; Department of Gastroenterology, Japanese Red Cross Masuda Hospital, Shimane, Japan.
  • Kobashi H; Department of Hepatology, Japanese Red Cross Okayama Hospital, Okayama, Japan.
  • Kimura H; Department of Gastroenterology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
  • Ogawa C; Department of Gastroenterology, Takamatsu Red Cross Hospital, Kagawa, Japan.
  • Yagisawa H; Department of Gastroenterology, Japanese Red Cross Akita Hospital, Akita, Japan.
  • Uchida Y; Department of Gastroenterology, Japanese Red Cross Matsue Hospital, Shimane, Japan.
  • Joko K; Center for Liver-Biliary-Pancreatic Diseases, Matsuyama Red Cross Hospital, Ehime, Japan.
  • Akahane T; Department of Gastroenterology, Japanese Red Cross Ishinomaki Hospital, Miyagi, Japan.
  • Arai H; Department of Gastroenterology, Japanese Red Cross Maebashi Hospital, Gunma, Japan.
  • Marusawa H; Department of Gastroenterology, Japanese Red Cross Osaka Hospital, Osaka, Japan.
  • Narita R; Department of Gastroenterology, Japanese Red Cross Oita Hospital, Oita, Japan.
  • Ide Y; Department of Gastroenterology, Japanese Red Cross Karatsu Hospital, Saga, Japan.
  • Sato T; Department of Gastroenterology, Japanese Red Cross Nasu Hospital, Tochigi, Japan.
  • Kusakabe A; Department of Gastroenterology, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan.
  • Tsuji K; Department of Gastroenterology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan.
  • Mori N; Department of Gastroenterology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan.
  • Kondo M; Department of Gastroenterology, Japanese Red Cross Otsu Hospital, Shiga, Japan.
  • Mitsuda A; Department of Internal Medicine, Japanese Red Cross Tottori Hospital, Tottori, Japan.
  • Izumi N; Department of Gastroenterology and Hepatology, Japanese Red Cross Musashino Hospital, Tokyo, Japan.
J Med Virol ; 93(11): 6247-6256, 2021 11.
Article em En | MEDLINE | ID: mdl-34170517
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Carbamatos / Hepacivirus / Hepatite C Crônica / Sofosbuvir / Compostos Heterocíclicos de 4 ou mais Anéis / Cirrose Hepática Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Carbamatos / Hepacivirus / Hepatite C Crônica / Sofosbuvir / Compostos Heterocíclicos de 4 ou mais Anéis / Cirrose Hepática Idioma: En Ano de publicação: 2021 Tipo de documento: Article